Teladoc Health, Inc. SEC Filing
Filer submitted a Form 144 reporting proposed sales of common stock related to compensation vesting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Filer submitted a Form 144 reporting proposed sales of common stock related to compensation vesting. The filing lists 16,314 shares under "Securities To Be Sold" with a date of 02/27/2026. It also records prior sales: 2,324 shares on 12/02/2025 and 4,209 shares on 12/03/2025.
The broker address shown is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI. The excerpt includes an NYSE listing and a numeric reference 178,396,434 alongside 03/02/2026.
Insights
Routine Form 144 disclosure of planned resale tied to restricted stock vesting.
The excerpt lists 16,314 common shares under "Securities To Be Sold" with a vesting date of 02/27/2026, and prior dispositions of 2,324 and 4,209 shares on 12/02/2025 and 12/03/2025. The filing identifies Fidelity Brokerage Services LLC as the broker.
These entries appear administrative: they report proposed resale following compensation vesting. Cash‑flow treatment and specific sale methods are not stated in the provided excerpt; subsequent filings or execution reports would show actual transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.